ADVFN - Advanced Financial Network.
HOME» NYSE » T » TMO Stock Price » TMO Stock News

Thermo Electron Share News

 Thermo Fisher Scientific Stock Price
TMO Stock Price
 Thermo Fisher Scientific Stock Chart
TMO Stock Chart
 Thermo Fisher Scientific Stock News
TMO Stock News
 Thermo Fisher Scientific Company Information
TMO Company Information
 Thermo Fisher Scientific Stock Trades
TMO Stock Trades

Thermo Fisher 1Q Net Rose 10%; Boosts Year View

DOW JONES NEWSWIRES Thermo Fisher Scientific Inc.'s (TMO) first-quarter earnings rose 10% as the supplier of analytical technologies and laboratory products saw increased revenue from all segments, though margins slipped on higher costs. Results topped expectations, and the company also raised its full-year earnings estimate to $4.71 to $4.83 a share on revenue of $12.27 billion to $12.43 billion from its February forecast of $4.67 to $4.82 a share on revenue between $12.15 billion to $12.35 billion. Thermo Fisher's sales have improved in recent quarters, aided by acquisitions and its expansion into Asia-Pacific markets. The company also launched new products last year to expand its mass spectrometry, specialty diagnostics and laboratory equipment lineup. But higher research and development costs, on top of restructuring and acquisition charges, have challenged its bottom line of late. Last month, Standard & Poor's Ratings Services lowered its outlook on Thermo Fisher to negative, citing uncertainty about the company's willingness to reduce debt after Thermo Fisher initiated a quarterly dividend. Thermo Fisher reported a profit of $277.3 million, or 75 cents a share, up from $252.2 million, or 63 cents, a year earlier. Excluding items such as asset amortization, restructuring and acquisition-related costs, earnings rose to $1.17 from 92 cents. Revenue jumped 14% to $3.1 billion. Analysts polled by Thomson Reuters had most recently forecast earnings of $1.11 on revenue of $2.98 billion. Operating margin dipped to 11.4% from 11.8% on higher costs. The laboratory products and services segment--the company's largest top-line contributor--saw a 4.5% revenue increase while its operating profit rose 1.2%. The analytical technologies segment's revenue jumped 21% and earnings grew 35%. Specialty diagnostics segment revenue increased 27%, while its income was up 31%. Shares closed Tuesday at $52.74 and were inactive premarket. The stock is up 17% so far this year. --By Melodie Warner, Dow Jones Newswires; 212-416-2283;

Stock News for Thermo Electron (TMO)
11/30/201517:28:41Free Writing Prospectus - Filing Under Securities Act Rules 163/433...
11/30/201517:24:00Thermo Fisher Scientific Prices Offering of Senior Notes
11/30/201508:54:07Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/24/201506:11:56Securities Registration (section 12(b)) (8-a12b)
11/24/201506:10:55Current Report Filing (8-k)
11/18/201516:08:12Current Report Filing (8-k)
11/17/201506:04:09Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/16/201508:51:35Current Report Filing (8-k)
11/13/201516:08:44Free Writing Prospectus - Filing Under Securities Act Rules 163/433...
11/13/201516:05:00Thermo Fisher Scientific Prices Offering of Euro-Denominated...
11/13/201506:12:27Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/12/201516:30:00Thermo Fisher Scientific Authorizes $1 Billion of Share Repurchases...
11/04/201518:00:00Singapore General Hospital & Thermo Fisher Scientific Collaborate...
11/04/201517:55:05Statement of Changes in Beneficial Ownership (4)
11/03/201517:35:12Statement of Changes in Beneficial Ownership (4)
11/03/201508:30:00Thermo Fisher Scientific to Present at Baird’s 2015 Industrial C...
10/30/201511:08:12Quarterly Report (10-q)
10/28/201516:22:40Initial Statement of Beneficial Ownership (3)
10/21/201506:00:00Thermo Fisher Scientific Reports Third Quarter 2015 Results

Thermo Electron and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations